XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
  Depression
  Neuropsychiatry
  Personality Disorders
  Bulimia
  Anxiety
  Substance Abuse
  Suicide
  CFS
  Psychoses
   Bipolar Disorder
   Schizophrenia
  Child Psychiatry
  Learning-Disabilities
  Psychology
  Forensic Psychiatry
  Mood Disorders
  Sleep Disorders
  Peri-Natal Psychiatry
  Psychotherapy
  Anorexia Nervosa
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38
Research Article

Schizophrenia Channel
subscribe to Schizophrenia newsletter

Latest Research : Psychiatry : Psychoses : Schizophrenia

   DISCUSS   |   EMAIL   |   PRINT
Hope of early diagnostic tool for schizophrenia and bipolar disorder
Aug 4, 2005, 23:50, Reviewed by: Dr.

"At the moment we don't have any biological tests for these conditions," said one of the authors, UNSW Associate Professor of Psychiatry, Philip Ward, who is based at Liverpool Hospital's Schizophrenia Research Unit. "Our research could eventually lead to a simple, cost-effective and safe way to distinguish patients with schizophrenia from those suffering bipolar disorder. This is important because a patient can get treatment sooner and hopefully have a better outcome."



 
Key research from the University of New South Wales (UNSW) could lead to the first early diagnostic tool for schizophrenia and bipolar disorder.
"At the moment we don't have any biological tests for these conditions," said one of the authors, UNSW Associate Professor of Psychiatry, Philip Ward, who is based at Liverpool Hospital's Schizophrenia Research Unit. "Our research could eventually lead to a simple, cost-effective and safe way to distinguish patients with schizophrenia from those suffering bipolar disorder. This is important because a patient can get treatment sooner and hopefully have a better outcome."

Auditory recovery cycle dysfunction in schizophrenia: A study using event-related potentials has just been published in the international journal Psychiatry Research.

"Sixty percent of patients with schizophrenia have auditory hallucinations," said co-author, UNSW PhD candidate Nathan Clunas. "So we decided to look at a particular brain wave-form which measures attention and attention deficits that can be found in these patients."

The researchers recorded the brain waves associated with pairs of sounds in 17 patients with schizophrenia. Subjects heard the sounds through a set of headphones, while performing a visual distraction task. The patients' results were compared with those of a sex and age-matched healthy volunteer group.

"We were looking at what occurs about 100 milliseconds after the sounds were presented," said Nathan Clunas. "The distinctive pattern observed in healthy volunteers was disrupted in patients with schizophrenia.

"These findings may help us understand the problems patients with schizophrenia experience in focussing attention on everyday events," said Nathan Clunas.

The researchers are currently analysing the results of patients with bipolar disorder, to see whether different patterns of response to sounds are seen in these patients.

"Depending on the final results in the bipolar group, we may be on the way to developing a biological test," said Professor Ward.

 

- Research Australia
 

 
Subscribe to Schizophrenia Newsletter
E-mail Address:

 

Nathan Clunas' PhD research was supported by an Ian Scott Fellowship from the Australian Rotary Health Research Fund.



Related Schizophrenia News

Study aims to identify schizophrenics at risk for type 2 diabetes
Effects of ketamine mimic only some of the symptoms of schizophrenia
Association between famine and schizophrenia may yield clues about genetic basis
Neuropeptide S (NPS) may help in treating schizophrenia
Neuropeptide S (NPS) may help in treating schizophrenia
NMDA receptor hypofunction demonstrated in schizophrenia
Altered NRG1-erbB4 signaling may contribute to NMDA receptor hypofunction in schizophrenia
Transcription factor Elk-1's role in neurodegeneration and schizophrenia
Schizophrenia limits one's ability to perceive body language
Hospitalized schizophrenics are at a higher risk for developing medical/surgical complications


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us